Improving Door-to-Needle Times in Acute Ischemic Stroke
Author(s) -
Gregg C. Fonarow,
Eric E. Smith,
Jeffrey L. Saver,
Mathew J. Reeves,
Adrian F. Hernandez,
Eric D. Peterson,
Ralph L. Sacco,
Lee H. Schwamm
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.621342
Subject(s) - medicine , stroke (engine) , acute stroke , ischemic stroke , cardiology , emergency medicine , intensive care medicine , ischemia , tissue plasminogen activator , mechanical engineering , engineering
The benefits of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke are time-dependent, and guidelines recommend a door-to-needle time of ≤60 minutes. However, fewer than one third of acute ischemic stroke patients who receive tPA are treated within guideline-recommended door-to-needle times. This article describes the design and rationale of
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom